🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Interferon alpha (IFNa) is involved in the pathogenesis of systemic lupus e...
Status
Completed
Location
Cliniques Universitaires St Luc
Start Date
2010-03
Trial ID
NCT01058343
Treatments Being Tested
The purpose of this study is to determine if combination of PUVA with inter...
Status
Terminated
Location
Hospital Príncipe de Asturias.
Start Date
2000-01
Trial ID
NCT00630903
Treatments Being Tested
This is a study of combination direct-acting antiviral agents (DAA) with or...
Status
Completed
Location
Site Reference ID/Investigator# 57583
Start Date
2011-10
Trial ID
NCT01464827
The purpose of this study is to evaluate the safety and efficacy of ABT-450...
Status
Completed
Location
Multiple Locations
Start Date
2013-02-25
Trial ID
NCT01782495
Treatments Being Tested
The human body knows a biphasic immunological reaction to sepsis. First, th...
Status
Completed
Location
Radboud University Nijmegen Medical Centre
Start Date
2011-05
Trial ID
NCT01374711
Treatments Being Tested
This study is a Proof of Concept study aiming to evaluate the production of...
Status
Withdrawn
Location
Research site
Start Date
2017-05-03
Trial ID
NCT02980198
Treatments Being Tested
The primary objectives of this study are to assess the safety of ABT-450/r/...
Status
Completed
Location
Multiple Locations
Start Date
2013-08-30
Trial ID
NCT01939197
Treatments Being Tested
The purpose of this Phase 2, open-label, 2-part, multicenter study was to e...
Status
Completed
Location
Multiple Locations
Start Date
2014-08
Trial ID
NCT02243280
The safety and immunogenicity of the IFNα-Kinoid (IFN-K) have been evaluate...
Status
Terminated
Location
Research Site
Start Date
2015-09-23
Trial ID
NCT02665364
Treatments Being Tested
Multi-center multinational-controlled study in Israel, Brazil, Spain, and S...
Status
Completed
Location
Rambam Medical Center
Start Date
2022-10-11
Trial ID
NCT05037162
Treatments Being Tested